Polyglandular syndrome (DC 7912)

Body system: Endocrine SystemRegulation: 38 CFR § 4.119

DC 7912 covers polyglandular syndromes, including multiple endocrine neoplasia (MEN) and autoimmune polyglandular syndrome (APS), conditions in which several endocrine glands fail or become overactive at once. DC 7912 itself has no rating ladder. Each major manifestation is rated separately under its own diagnostic code per 38 CFR § 4.119, including (but not limited to) Type I diabetes mellitus (DC 7913), hyperthyroidism (DC 7900), hypothyroidism (DC 7903), hypoparathyroidism (DC 7905), or Addison's disease (DC 7911). The separate ratings are then combined under 38 CFR § 4.25, with the anti-pyramiding rule (§ 4.14) preventing the same impairment from being rated twice.

Rating levels

  • -1% — Polyglandular syndromes are conditions in which several endocrine glands fail or become overactive at once. VA does not assign a single percentage to DC 7912 itself. Instead, each affected gland is rated under its own diagnostic code per 38 CFR § 4.119, and the resulting ratings are combined under § 4.25. The anti-pyramiding rule (§ 4.14) prevents the same impairment from being rated under more than one code.
  • -1% — The CFR Note lists the most common manifestations that trigger separate evaluation under their own diagnostic codes: Type I diabetes mellitus (rated under DC 7913), hyperthyroidism (DC 7900), hypothyroidism (DC 7903), hypoparathyroidism (DC 7905), and Addison's disease (DC 7911). The list is illustrative, not exhaustive ("include, but not limited to"), so any other endocrine manifestation that is part of the polyglandular syndrome (for example, premature ovarian failure, pernicious anemia, or vitiligo) is also evaluated under its own diagnostic code where one applies.

Disclaimer: This tool is for informational purposes only and is not legal or medical advice. Always consult with your VSO representative or a qualified veterans benefits attorney for guidance on your specific claim.